Moolec Science SA (MLEC) Form 6-K — Sep 2, 2026
Moolec Science SA disclosed that the shareholder and related-party financial support it had relied on to meet liquidity needs is no longer available, and that this, combined with a pending winding-up petition, is a material adverse development that significantly increases the uncertainty about its ability to continue as a going concern. The company, which reported negative working capital as of December 31, 2025, said it must now obtain replacement financing or other financial support to satisfy its obligations as they come due, despite cost-cutting and restructuring measures implemented since current management took over.
Key figures
- Working capital position
- Negative as of December 31, 2025
- Linklaters legal fees paid
- $3.8 million
- Shareholders equity position
- Positive as of December 31, 2025
- Linklaters legal fees invoiced
- $6.1 million (January 2023 through June 2025)
- Disputed amount asserted by linklaters
- $2.3 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.